Back to DirectoryParenteral Nutrition
Parenteral Nutrition

Clinimix 5/10 sulfite free in dextrose 10% in plastic container

Osmolarity: ≈ 844 mOsm/LTonicity: HypertonicpH: 6.0

Clinical Indications

Parenteral nutrition for patients requiring caloric and protein support without additional electrolytes. Allows customized electrolyte additions.

Dosing & Administration Rate

Individualized based on nutritional requirements. Monitor blood glucose, fluid balance, and serum electrolytes daily.

Warnings & Precautions

High osmolarity requires central access. Monitor for refeeding syndrome in severely malnourished patients.

Contraindications

Known hypersensitivity to amino acids. Severe liver disease or hepatic coma. Severe renal impairment (without dialysis). Abnormalities of amino acid metabolism.

Pharmacology & Safety Profile

Mechanism of Action

Provides a source of biologically utilizable essential and non-essential amino acids for protein synthesis, and dextrose as a source of calories.

Adverse Reactions

Phlebitis, fluid overload, hyperglycemia, hyperosmolar syndrome, electrolyte imbalances, metabolic acidosis, liver enzyme elevations.

Compatibility Notes

Electrolytes and trace elements added per patient need. Check calcium-phosphate solubility curves.

Electrolyte & Composition Profile

ComponentAmount / Concentration
Amino Acids50 g/L (5%)
Dextrose (Anhydrous)100 g/L (10%)
Water for Injectionq.s.
Caloric Density340 kcal/L (from dextrose), 200 kcal/L (from protein)
Nitrogen Content8 g/L

Clinical Parameters

RouteIntravenous (infusion)
Fluid CategoryParenteral Nutrition
Required MonitoringVital signs, fluid intake/output, baseline electrolytes
Administration SetupCentral venous line strongly recommended due to high osmolarity. Use infusion pump.
Pregnancy SafetyCategory C (FDA). Animal reproduction studies have not been conducted. Should be given to a pregnant woman only if clearly needed.
StorageStore at room temperature. Protect from light.
Prescription Status Rx Only

Clinical Disclaimer: Data compiled from FDA DailyMed, Baxter/Fresenius prescribing information, and USP monographs. Always verify against the physical product label, your institution's IV protocols, and current pharmacist guidance before administration.